# Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient

> **NCT03806764** · NA · UNKNOWN · sponsor: **Melbourne Health** · enrollment: 370 (estimated)

## Conditions studied

- Cytomegalovirus Infections
- Haematological Malignancy
- Organ or Tissue Transplant; Complications
- Immune Suppression

## Interventions

- **DIAGNOSTIC_TEST:** Blood sampling

## Key facts

- **NCT ID:** NCT03806764
- **Lead sponsor:** Melbourne Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-04-17
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 370 (ESTIMATED)
- **Last updated:** 2023-06-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03806764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03806764, "Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03806764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*